The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function

Richard J. Knight, Ronald H. Kerman, Linda Schoenberg, Hemangshu Podder, Charles T. Van Buren, Stephen Katz, Barry D. Kahan

Research output: Contribution to journalReview articlepeer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function'. Together they form a unique fingerprint.

Medicine & Life Sciences